PD-L1 Expression and Clinical Outcomes to Cabozantinib,...

Clinical Cancer Research 2019 / 10 Vol. 25; Iss. 20

PD-L1 Expression and Clinical Outcomes to Cabozantinib, Everolimus, and Sunitinib in Patients with Metastatic Renal Cell Carcinoma: Analysis of the Randomized Clinical Trials METEOR and CABOSUN

Flaifel, Abdallah, Xie, Wanling, Braun, David A., Ficial, Miriam, Bakouny, Ziad, Nassar, Amin H., Jennings, Rebecca B., Escudier, Bernard, George, Daniel J., Motzer, Robert J., Morris, Michael J., Pow
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
25
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-19-1135
Date:
October, 2019
File:
PDF, 354 KB
2019
Conversion to is in progress
Conversion to is failed